[
{
"old_id":"1",
"old_nametree":"Overview",
"old_numtree":"1.0.0.0",
"old_htmlpage":"ENAS6572_1.0.0.0",
"new_id":"1",
"new_nametree":"Overview",
"new_numtree":"1.0.0.0",
"new_htmlpage":"ENAS6572_1.0.0.0"
},
{
"old_id":"2",
"old_nametree":"The Risk Calculator",
"old_numtree":"2.0.0.0",
"old_htmlpage":"ENAS6572_2.0.0.0",
"new_id":"2",
"new_nametree":"The Risk Calculator",
"new_numtree":"2.0.0.0",
"new_htmlpage":"ENAS6572_2.0.0.0"
},
{
"old_id":"3",
"old_nametree":"Hypertension/Blood Pressure Control",
"old_numtree":"3.0.0.0",
"old_htmlpage":"null",
"new_id":"3",
"new_nametree":"Hypertension/Blood Pressure Control",
"new_numtree":"3.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"4",
"old_nametree":"Overview",
"old_numtree":"3.1.0.0",
"old_htmlpage":"ENAS6572_3.1.0.0",
"new_id":"4",
"new_nametree":"Overview",
"new_numtree":"3.1.0.0",
"new_htmlpage":"ENAS6572_3.1.0.0"
},
{
"old_id":"5",
"old_nametree":"Screening and Diagnosis",
"old_numtree":"3.2.0.0",
"old_htmlpage":"null",
"new_id":"5",
"new_nametree":"Screening and Diagnosis",
"new_numtree":"3.2.0.0",
"new_htmlpage":"null"
},
{
"old_id":"6",
"old_nametree":"Recommendations",
"old_numtree":"3.2.1.0",
"old_htmlpage":"ENAS6572_3.2.1.0",
"new_id":"6",
"new_nametree":"Recommendations",
"new_numtree":"3.2.1.0",
"new_htmlpage":"ENAS6572_3.2.1.0"
},
{
"old_id":"7",
"old_nametree":"Overview",
"old_numtree":"3.2.2.0",
"old_htmlpage":"ENAS6572_3.2.2.0",
"new_id":"7",
"new_nametree":"Overview",
"new_numtree":"3.2.2.0",
"new_htmlpage":"ENAS6572_3.2.2.0"
},
{
"old_id":"8",
"old_nametree":"Treatment Goals",
"old_numtree":"3.3.0.0",
"old_htmlpage":"null",
"new_id":"8",
"new_nametree":"Treatment Goals",
"new_numtree":"3.3.0.0",
"new_htmlpage":"null"
},
{
"old_id":"9",
"old_nametree":"Recommendations",
"old_numtree":"3.3.1.0",
"old_htmlpage":"ENAS6572_3.3.1.0",
"new_id":"9",
"new_nametree":"Recommendations",
"new_numtree":"3.3.1.0",
"new_htmlpage":"ENAS6572_3.3.1.0"
},
{
"old_id":"10",
"old_nametree":"Overview",
"old_numtree":"3.3.2.0",
"old_htmlpage":"ENAS6572_3.3.2.0",
"new_id":"10",
"new_nametree":"Overview",
"new_numtree":"3.3.2.0",
"new_htmlpage":"ENAS6572_3.3.2.0"
},
{
"old_id":"11",
"old_nametree":"Randomized Controlled Trials of Intensive Versus Standard Blood Pressure Control",
"old_numtree":"3.3.3.0",
"old_htmlpage":"ENAS6572_3.3.3.0",
"new_id":"11",
"new_nametree":"Randomized Controlled Trials of Intensive Versus Standard Blood Pressure Control",
"new_numtree":"3.3.3.0",
"new_htmlpage":"ENAS6572_3.3.3.0"
},
{
"old_id":"12",
"old_nametree":"Meta-analyses of Trials",
"old_numtree":"3.3.4.0",
"old_htmlpage":"ENAS6572_3.3.4.0",
"new_id":"12",
"new_nametree":"Meta-analyses of Trials",
"new_numtree":"3.3.4.0",
"new_htmlpage":"ENAS6572_3.3.4.0"
},
{
"old_id":"13",
"old_nametree":"Individualization of Treatment Targets",
"old_numtree":"3.3.5.0",
"old_htmlpage":"ENAS6572_3.3.5.0",
"new_id":"13",
"new_nametree":"Individualization of Treatment Targets",
"new_numtree":"3.3.5.0",
"new_htmlpage":"ENAS6572_3.3.5.0"
},
{
"old_id":"14",
"old_nametree":"Pregnancy and Antihypertensive Medications",
"old_numtree":"3.3.6.0",
"old_htmlpage":"ENAS6572_3.3.6.0",
"new_id":"14",
"new_nametree":"Pregnancy and Antihypertensive Medications",
"new_numtree":"3.3.6.0",
"new_htmlpage":"ENAS6572_3.3.6.0"
},
{
"old_id":"15",
"old_nametree":"Treatment Strategies",
"old_numtree":"3.4.0.0",
"old_htmlpage":"null",
"new_id":"15",
"new_nametree":"Treatment Strategies",
"new_numtree":"3.4.0.0",
"new_htmlpage":"null"
},
{
"old_id":"16",
"old_nametree":"Lifestyle Intervention",
"old_numtree":"3.4.1.0",
"old_htmlpage":"ENAS6572_3.4.1.0",
"new_id":"16",
"new_nametree":"Lifestyle Intervention",
"new_numtree":"3.4.1.0",
"new_htmlpage":"ENAS6572_3.4.1.0"
},
{
"old_id":"17",
"old_nametree":"Pharmacologic Interventions",
"old_numtree":"3.4.2.0",
"old_htmlpage":"null",
"new_id":"17",
"new_nametree":"Pharmacologic Interventions",
"new_numtree":"3.4.2.0",
"new_htmlpage":"null"
},
{
"old_id":"18",
"old_nametree":"Recommendations",
"old_numtree":"3.4.2.1",
"old_htmlpage":"ENAS6572_3.4.2.1",
"new_id":"18",
"new_nametree":"Recommendations",
"new_numtree":"3.4.2.1",
"new_htmlpage":"ENAS6572_3.4.2.1"
},
{
"old_id":"19",
"old_nametree":"Initial Number of Antihypertensive Medications",
"old_numtree":"3.4.2.2",
"old_htmlpage":"ENAS6572_3.4.2.2",
"new_id":"19",
"new_nametree":"Initial Number of Antihypertensive Medications",
"new_numtree":"3.4.2.2",
"new_htmlpage":"ENAS6572_3.4.2.2"
},
{
"old_id":"20",
"old_nametree":"Classes of Antihypertensive Medications",
"old_numtree":"3.4.2.3",
"old_htmlpage":"ENAS6572_3.4.2.3",
"new_id":"20",
"new_nametree":"Classes of Antihypertensive Medications",
"new_numtree":"3.4.2.3",
"new_htmlpage":"ENAS6572_3.4.2.3"
},
{
"old_id":"21",
"old_nametree":"Multiple-Drug Therapy",
"old_numtree":"3.4.2.4",
"old_htmlpage":"ENAS6572_3.4.2.4",
"new_id":"21",
"new_nametree":"Multiple-Drug Therapy",
"new_numtree":"3.4.2.4",
"new_htmlpage":"ENAS6572_3.4.2.4"
},
{
"old_id":"22",
"old_nametree":"Bedtime Dosing",
"old_numtree":"3.4.2.5",
"old_htmlpage":"ENAS6572_3.4.2.5",
"new_id":"22",
"new_nametree":"Bedtime Dosing",
"new_numtree":"3.4.2.5",
"new_htmlpage":"ENAS6572_3.4.2.5"
},
{
"old_id":"23",
"old_nametree":"Hyperkalemia and Acute Kidney Injury",
"old_numtree":"3.4.2.6",
"old_htmlpage":"ENAS6572_3.4.2.6",
"new_id":"23",
"new_nametree":"Hyperkalemia and Acute Kidney Injury",
"new_numtree":"3.4.2.6",
"new_htmlpage":"ENAS6572_3.4.2.6"
},
{
"old_id":"24",
"old_nametree":"Resistant Hypertension",
"old_numtree":"3.4.3.0",
"old_htmlpage":"ENAS6572_3.4.3.0",
"new_id":"24",
"new_nametree":"Resistant Hypertension",
"new_numtree":"3.4.3.0",
"new_htmlpage":"ENAS6572_3.4.3.0"
},
{
"old_id":"25",
"old_nametree":"Lipid Management",
"old_numtree":"4.0.0.0",
"old_htmlpage":"null",
"new_id":"25",
"new_nametree":"Lipid Management",
"new_numtree":"4.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"26",
"old_nametree":"Lifestyle Intervention",
"old_numtree":"4.1.0.0",
"old_htmlpage":"ENAS6572_4.1.0.0",
"new_id":"26",
"new_nametree":"Lifestyle Intervention",
"new_numtree":"4.1.0.0",
"new_htmlpage":"ENAS6572_4.1.0.0"
},
{
"old_id":"27",
"old_nametree":"Ongoing Therapy and Monitoring With Lipid Panel",
"old_numtree":"4.2.0.0",
"old_htmlpage":"ENAS6572_4.2.0.0",
"new_id":"27",
"new_nametree":"Ongoing Therapy and Monitoring With Lipid Panel",
"new_numtree":"4.2.0.0",
"new_htmlpage":"ENAS6572_4.2.0.0"
},
{
"old_id":"28",
"old_nametree":"Statin Treatment",
"old_numtree":"5.0.0.0",
"old_htmlpage":"null",
"new_id":"28",
"new_nametree":"Statin Treatment",
"new_numtree":"5.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"29",
"old_nametree":"Primary Prevention",
"old_numtree":"5.1.0.0",
"old_htmlpage":"ENAS6572_5.1.0.0",
"new_id":"29",
"new_nametree":"Primary Prevention",
"new_numtree":"5.1.0.0",
"new_htmlpage":"ENAS6572_5.1.0.0"
},
{
"old_id":"30",
"old_nametree":"Secondary Prevention",
"old_numtree":"5.2.0.0",
"old_htmlpage":"ENAS6572_5.2.0.0",
"new_id":"30",
"new_nametree":"Secondary Prevention",
"new_numtree":"5.2.0.0",
"new_htmlpage":"ENAS6572_5.2.0.0"
},
{
"old_id":"31",
"old_nametree":"Initiating Statin Therapy Based on Risk",
"old_numtree":"5.3.0.0",
"old_htmlpage":"null",
"new_id":"31",
"new_nametree":"Initiating Statin Therapy Based on Risk",
"new_numtree":"5.3.0.0",
"new_htmlpage":"null"
},
{
"old_id":"32",
"old_nametree":"Overview",
"old_numtree":"5.3.1.0",
"old_htmlpage":"ENAS6572_5.3.1.0",
"new_id":"32",
"new_nametree":"Overview",
"new_numtree":"5.3.1.0",
"new_htmlpage":"ENAS6572_5.3.1.0"
},
{
"old_id":"33",
"old_nametree":"Primary Prevention (Patients Without ASCVD)",
"old_numtree":"5.3.2.0",
"old_htmlpage":"ENAS6572_5.3.2.0",
"new_id":"33",
"new_nametree":"Primary Prevention (Patients Without ASCVD)",
"new_numtree":"5.3.2.0",
"new_htmlpage":"ENAS6572_5.3.2.0"
},
{
"old_id":"34",
"old_nametree":"Age <40 Years and/or Type 1 Diabetes",
"old_numtree":"5.3.3.0",
"old_htmlpage":"ENAS6572_5.3.3.0",
"new_id":"34",
"new_nametree":"Age <40 Years and/or Type 1 Diabetes",
"new_numtree":"5.3.3.0",
"new_htmlpage":"ENAS6572_5.3.3.0"
},
{
"old_id":"35",
"old_nametree":"Secondary Prevention (Patients With ASCVD)",
"old_numtree":"5.3.4.0",
"old_htmlpage":"ENAS6572_5.3.4.0",
"new_id":"35",
"new_nametree":"Secondary Prevention (Patients With ASCVD)",
"new_numtree":"5.3.4.0",
"new_htmlpage":"ENAS6572_5.3.4.0"
},
{
"old_id":"36",
"old_nametree":"Combination Therapy for LDL Cholesterol Lowering",
"old_numtree":"5.4.0.0",
"old_htmlpage":"null",
"new_id":"36",
"new_nametree":"Combination Therapy for LDL Cholesterol Lowering",
"new_numtree":"5.4.0.0",
"new_htmlpage":"null"
},
{
"old_id":"37",
"old_nametree":"Statins and Ezetimibe",
"old_numtree":"5.4.1.0",
"old_htmlpage":"ENAS6572_5.4.1.0",
"new_id":"37",
"new_nametree":"Statins and Ezetimibe",
"new_numtree":"5.4.1.0",
"new_htmlpage":"ENAS6572_5.4.1.0"
},
{
"old_id":"38",
"old_nametree":"Statins and PCSK9 Inhibitors",
"old_numtree":"5.4.2.0",
"old_htmlpage":"ENAS6572_5.4.2.0",
"new_id":"38",
"new_nametree":"Statins and PCSK9 Inhibitors",
"new_numtree":"5.4.2.0",
"new_htmlpage":"ENAS6572_5.4.2.0"
},
{
"old_id":"39",
"old_nametree":"Statins and Bempedoic Acid",
"old_numtree":"5.4.3.0",
"old_htmlpage":"ENAS6572_5.4.3.0",
"new_id":"39",
"new_nametree":"Statins and Bempedoic Acid",
"new_numtree":"5.4.3.0",
"new_htmlpage":"ENAS6572_5.4.3.0"
},
{
"old_id":"40",
"old_nametree":"Treatment of Other Lipoprotein Fractions or Targets",
"old_numtree":"5.5.0.0",
"old_htmlpage":"ENAS6572_5.5.0.0",
"new_id":"40",
"new_nametree":"Treatment of Other Lipoprotein Fractions or Targets",
"new_numtree":"5.5.0.0",
"new_htmlpage":"ENAS6572_5.5.0.0"
},
{
"old_id":"41",
"old_nametree":"Other Combination Therapy",
"old_numtree":"5.6.0.0",
"old_htmlpage":"null",
"new_id":"41",
"new_nametree":"Other Combination Therapy",
"new_numtree":"5.6.0.0",
"new_htmlpage":"null"
},
{
"old_id":"42",
"old_nametree":"Recommendations",
"old_numtree":"5.6.1.0",
"old_htmlpage":"ENAS6572_5.6.1.0",
"new_id":"42",
"new_nametree":"Recommendations",
"new_numtree":"5.6.1.0",
"new_htmlpage":"ENAS6572_5.6.1.0"
},
{
"old_id":"43",
"old_nametree":"Statin and Fibrate Combination Therapy",
"old_numtree":"5.6.2.0",
"old_htmlpage":"ENAS6572_5.6.2.0",
"new_id":"43",
"new_nametree":"Statin and Fibrate Combination Therapy",
"new_numtree":"5.6.2.0",
"new_htmlpage":"ENAS6572_5.6.2.0"
},
{
"old_id":"44",
"old_nametree":"Statin and Niacin Combination Therapy",
"old_numtree":"5.6.3.0",
"old_htmlpage":"ENAS6572_5.6.3.0",
"new_id":"44",
"new_nametree":"Statin and Niacin Combination Therapy",
"new_numtree":"5.6.3.0",
"new_htmlpage":"ENAS6572_5.6.3.0"
},
{
"old_id":"45",
"old_nametree":"Diabetes Risk With Statin Use",
"old_numtree":"5.7.0.0",
"old_htmlpage":"ENAS6572_5.7.0.0",
"new_id":"45",
"new_nametree":"Diabetes Risk With Statin Use",
"new_numtree":"5.7.0.0",
"new_htmlpage":"ENAS6572_5.7.0.0"
},
{
"old_id":"46",
"old_nametree":"Lipid-Lowering Agents and Cognitive Function",
"old_numtree":"5.8.0.0",
"old_htmlpage":"ENAS6572_5.8.0.0",
"new_id":"46",
"new_nametree":"Lipid-Lowering Agents and Cognitive Function",
"new_numtree":"5.8.0.0",
"new_htmlpage":"ENAS6572_5.8.0.0"
},
{
"old_id":"47",
"old_nametree":"Antiplatelet Agents",
"old_numtree":"6.0.0.0",
"old_htmlpage":"null",
"new_id":"47",
"new_nametree":"Antiplatelet Agents",
"new_numtree":"6.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"48",
"old_nametree":"Recommendations",
"old_numtree":"6.1.0.0",
"old_htmlpage":"ENAS6572_6.1.0.0",
"new_id":"48",
"new_nametree":"Recommendations",
"new_numtree":"6.1.0.0",
"new_htmlpage":"ENAS6572_6.1.0.0"
},
{
"old_id":"49",
"old_nametree":"Risk Reduction",
"old_numtree":"6.2.0.0",
"old_htmlpage":"ENAS6572_6.2.0.0",
"new_id":"49",
"new_nametree":"Risk Reduction",
"new_numtree":"6.2.0.0",
"new_htmlpage":"ENAS6572_6.2.0.0"
},
{
"old_id":"50",
"old_nametree":"Aspirin Use in People <50 Years of Age",
"old_numtree":"6.3.0.0",
"old_htmlpage":"ENAS6572_6.3.0.0",
"new_id":"50",
"new_nametree":"Aspirin Use in People <50 Years of Age",
"new_numtree":"6.3.0.0",
"new_htmlpage":"ENAS6572_6.3.0.0"
},
{
"old_id":"51",
"old_nametree":"Aspirin Dosing",
"old_numtree":"6.4.0.0",
"old_htmlpage":"ENAS6572_6.4.0.0",
"new_id":"51",
"new_nametree":"Aspirin Dosing",
"new_numtree":"6.4.0.0",
"new_htmlpage":"ENAS6572_6.4.0.0"
},
{
"old_id":"52",
"old_nametree":"Indications for P2Y12 Receptor Antagonist Use",
"old_numtree":"6.5.0.0",
"old_htmlpage":"ENAS6572_6.5.0.0",
"new_id":"52",
"new_nametree":"Indications for P2Y12 Receptor Antagonist Use",
"new_numtree":"6.5.0.0",
"new_htmlpage":"ENAS6572_6.5.0.0"
},
{
"old_id":"53",
"old_nametree":"Combination Antiplatelet and Anticoagulation Therapy",
"old_numtree":"6.6.0.0",
"old_htmlpage":"ENAS6572_6.6.0.0",
"new_id":"53",
"new_nametree":"Combination Antiplatelet and Anticoagulation Therapy",
"new_numtree":"6.6.0.0",
"new_htmlpage":"ENAS6572_6.6.0.0"
},
{
"old_id":"54",
"old_nametree":"Cardiovascular Disease",
"old_numtree":"7.0.0.0",
"old_htmlpage":"null",
"new_id":"54",
"new_nametree":"Cardiovascular Disease",
"new_numtree":"7.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"55",
"old_nametree":"Screening",
"old_numtree":"7.1.0.0",
"old_htmlpage":"ENAS6572_7.1.0.0",
"new_id":"55",
"new_nametree":"Screening",
"new_numtree":"7.1.0.0",
"new_htmlpage":"ENAS6572_7.1.0.0"
},
{
"old_id":"56",
"old_nametree":"Treatment",
"old_numtree":"7.2.0.0",
"old_htmlpage":"ENAS6572_7.2.0.0",
"new_id":"56",
"new_nametree":"Treatment",
"new_numtree":"7.2.0.0",
"new_htmlpage":"ENAS6572_7.2.0.0"
},
{
"old_id":"57",
"old_nametree":"Cardiac Testing",
"old_numtree":"7.3.0.0",
"old_htmlpage":"ENAS6572_7.3.0.0",
"new_id":"57",
"new_nametree":"Cardiac Testing",
"new_numtree":"7.3.0.0",
"new_htmlpage":"ENAS6572_7.3.0.0"
},
{
"old_id":"58",
"old_nametree":"Screening Asymptomatic Patients",
"old_numtree":"7.4.0.0",
"old_htmlpage":"ENAS6572_7.4.0.0",
"new_id":"58",
"new_nametree":"Screening Asymptomatic Patients",
"new_numtree":"7.4.0.0",
"new_htmlpage":"ENAS6572_7.4.0.0"
},
{
"old_id":"59",
"old_nametree":"Lifestyle and Pharmacologic Interventions",
"old_numtree":"7.5.0.0",
"old_htmlpage":"ENAS6572_7.5.0.0",
"new_id":"59",
"new_nametree":"Lifestyle and Pharmacologic Interventions",
"new_numtree":"7.5.0.0",
"new_htmlpage":"ENAS6572_7.5.0.0"
},
{
"old_id":"60",
"old_nametree":"Glucose-Lowering Therapies and Cardiovascular Outcomes",
"old_numtree":"7.6.0.0",
"old_htmlpage":"null",
"new_id":"60",
"new_nametree":"Glucose-Lowering Therapies and Cardiovascular Outcomes",
"new_numtree":"7.6.0.0",
"new_htmlpage":"null"
},
{
"old_id":"61",
"old_nametree":"Overview",
"old_numtree":"7.6.1.0",
"old_htmlpage":"ENAS6572_7.6.1.0",
"new_id":"61",
"new_nametree":"Overview",
"new_numtree":"7.6.1.0",
"new_htmlpage":"ENAS6572_7.6.1.0"
},
{
"old_id":"62",
"old_nametree":"SGLT2 Inhibitor Trials",
"old_numtree":"7.6.2.0",
"old_htmlpage":"ENAS6572_7.6.2.0",
"new_id":"62",
"new_nametree":"SGLT2 Inhibitor Trials",
"new_numtree":"7.6.2.0",
"new_htmlpage":"ENAS6572_7.6.2.0"
},
{
"old_id":"63",
"old_nametree":"GLP-1 Receptor Agonist Trials",
"old_numtree":"7.6.3.0",
"old_htmlpage":"ENAS6572_7.6.3.0",
"new_id":"63",
"new_nametree":"GLP-1 Receptor Agonist Trials",
"new_numtree":"7.6.3.0",
"new_htmlpage":"ENAS6572_7.6.3.0"
},
{
"old_id":"64",
"old_nametree":"Glucose-Lowering Therapies and Heart Failure",
"old_numtree":"7.6.4.0",
"old_htmlpage":"ENAS6572_7.6.4.0",
"new_id":"64",
"new_nametree":"Glucose-Lowering Therapies and Heart Failure",
"new_numtree":"7.6.4.0",
"new_htmlpage":"ENAS6572_7.6.4.0"
},
{
"old_id":"65",
"old_nametree":"Clinical Approach",
"old_numtree":"7.6.5.0",
"old_htmlpage":"ENAS6572_7.6.5.0",
"new_id":"65",
"new_nametree":"Clinical Approach",
"new_numtree":"7.6.5.0",
"new_htmlpage":"ENAS6572_7.6.5.0"
},
{
"old_id":"66",
"old_nametree":"References",
"old_numtree":"8.0.0.0",
"old_htmlpage":"ENAS6572_8.0.0.0",
"new_id":"66",
"new_nametree":"References",
"new_numtree":"8.0.0.0",
"new_htmlpage":"ENAS6572_8.0.0.0"
}
]